[1] 贺艮峰, 钟树荣, 景强. 酒精依赖相关基因的遗传多态性. 遗传, 2008, 30(4): 413–418.
[2] Liang TB, Spence J, Liu LX, Strother WN, Chang HW, Ellison JA, Lumeng L, Li TK, Foroud T, Carr LG. α-Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alco-hol-preferring and -nonpreferring rats. Proc Natl Acad Sci USA, 2003, 100(8): 4690–4695.
[3] Farrer M. The Genetics and molecular biology of al-pha-synuclein. Handb Clin Neurol, 2008, 89: 313–319.
[4] Spence JP, Liang TB, Liu LX, Johnson PL, Foroud T, Carr LG, Shekhar A. From QTL to candidate gene: a genetic approach to alcoholism research. Curr Drug Abuse Rev, 2009, 2(2): 127–134.
[5] Pankratz N, Nichols WC, Elsaesser VE, Pauciulo MW, Marek DK, Halter CA, Wojcieszek J, Rudolph A, Pfeiffer RF, Foroud T, Parkinson Study Group-PROGENI Investi-gators. Alpha-synuclein and familial Parkinson's disease. Mov Disord, 2009, 24(8): 1125–1131.
[6] Perez RG, Waymire JC, Lin E, Liu JJ, Guo FL, Zigmond MJ. A role for α-synuclein in the regulation of dopamine biosynthesis. J Neurosci, 2002, 22(8): 3090–3099.
[7] Tehranian R, Montoya SE, van Laar AD, Hastings TG, Perez RG. Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells. J Neurochem, 2006, 99(4): 1188–1196.
[8] Liu DM, Jin L, Wang H, Zhao HY, Zhao CL, Duan CL, Lu LL, Wu B, Yu S, Chan P, Li YH, Yang H. Silencing α-synuclein gene expression enhances tyrosine hydroxy-lase activity in MN9D cells. Neurochem Res, 2008, 33(7): 1401–1409.
[9] Peng XM, Tehranian R, Dietrich P, Stefanis L, Perez RG. α-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J Cell Sci, 2005, 118(15): 3523–3530.
[10] Baptista MJ, O'Farrell C, Daya S, Ahmad R, Miller DW, Hardy J, Farrer MJ, Cookson MR. Co-ordinate transcrip-tional regulation of dopamine synthesis genes by al-pha-synuclein in human neuroblastoma cell lines. J Neu-rochem, 2003, 85(4): 957–968.
[11] Yu S, Zuo XH, Li YH, Zhang C, Zhou M, Zhang YA, Uéda K, Chan P. Inhibition of tyrosine hydroxylase ex-pression in alpha-synuclein-transfected dopaminergic neu-ronal cells. Neurosci Lett, 2004, 367(1): 34–39.
[12] Gao N, Li YH, Li X, Yu S, Fu GL, Chen B. Effect of α-synuclein on the promoter activity of tyrosine hydroxy-lase gene. Neurosci Bull, 2007, 23(1): 53–57.
[13] Jenco JM, Rawlingson A, Daniels B, Morris AJ. Regula-tion of phospholipase D2: selective inhibition of mam-malian phospholipase D isoenzymes by α- and β-synucleins. Biochemistry, 1998, 37(14): 4901-4909.
[14] Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. Synu-cleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in pri-mary hippocampal neurons. J Neurosci, 2000, 20(9): 3214–3220.
[15] Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P. Effect of mutant α-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem, 2002, 277(41): 38884–38894.
[16] Larsen KE, Schmitz Y, Troyer MD, Mosharov E, Dietrich P, Quazi AZ, Savalle M, Nemani V, Chaudhry FA, Ed-wards RH, Stefanis L, Sulzer D. α-synuclein overexpres-sion in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci, 2006, 26(46): 11915–11922.
[17] Abeliovich A, Schmitz Y, Fariñas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JMG, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron, 2000, 25(1): 239–252.
[18] Adamczyk A, Ka?mierczak A, Strosznajder JB. Al-pha-synuclein and its neurotoxic
